Both eIF4F formation and the eIF4A helicase activity have been investigated as potential targets for inhibitors which could be used to specifically inhibit mRNA translation in cancer cells [13–16] with eIF4A inhibitors also investigated for antiviral activity [17,18]. Here, EIF4A2 is linked to cancer.